A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well-Controlled Type 1 Diabetes Mellitus

A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well-Controlled Type 1 Diabetes Mellitus

This study evaluated the safety and efficacy of tubeless patch pump called EOPatch in patients with well-controlled type 1 diabetes mellitus (T1DM). This 4-week, two-center, open-label, single-arm study enrolled 10 adult patients diagnosed with T1DM with glycosylated hemoglobin less than 7.5%. The c...

Full description

Bibliographic Details
Main Authors: Jiyun Park, Nammi Park, Sangjin Han, You-Bin Lee, Gyuri Kim, Sang-Man Jin, Woo Je Lee, Jae Hyeon Kim
Format: Article
Language:English
Published: Korean Diabetes Association 2022-11-01
Series:Diabetes & Metabolism Journal
Subjects:
diabetes mellitus, type 1
glycated hemoglobin a
insulin
insulin infusion systems
Online Access:http://e-dmj.org/upload/pdf/dmj-2021-0299.pdf

Internet

http://e-dmj.org/upload/pdf/dmj-2021-0299.pdf

Similar Items